An official website of the United States government
NIH Guide: Weekly Index for June 16, 2023
Weekly NIH Funding Opportunities and Notices
June 16, 2023
Policy Notices
-
Notice of Clarification for PA-21-264, PA-21-265, PA-22-047, and PA-22-048
(NOT-HS-23-014)Agency for Healthcare Research and Quality
General Notices
-
Notice of Pre-Application Webinar for RFA-AG-24-036, "Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)?"
(NOT-AG-23-033)National Institute on Aging
-
Pre-Solicitation Notice: Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models, RFP: 75N95023R00047
(NOT-DA-23-027)National Institute on Drug Abuse
-
Notice of Information: NICHD to issue a sole source award to support the Designing a Public-Private Partnership to Support Pediatric Medical Device Development and Commercialization project
(NOT-HD-23-018)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Biomedical Imaging and Bioengineering
-
Request for Information (RFI): Inviting Comments and Suggestions on Updating the NIAID Strategic Plan for Tuberculosis Research
(NOT-AI-23-052)National Institute of Allergy and Infectious Diseases
-
Request for Information (RFI): Inviting comments on the NIBIB 2024-2028 Strategic Plan Framework
(NOT-EB-23-004)National Institute of Biomedical Imaging and Bioengineering
-
Request for Information on Catalyzing the Development and Use of Novel Alternative Methods to Advance Biomedical Research
(NOT-OD-23-140)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Participation of the National Institute on Aging (NIA) in PAR-22-080, "Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)"
(NOT-AG-23-029)National Institute on Aging
-
Notice of Change to Eligibility Information in RFA-AG-24-038, "Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)"
(NOT-AG-23-035)National Institute on Aging
-
Notice of Change to Application Due Date for RFA-AT-24-003 "HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)"
(NOT-AT-24-009)National Center for Complementary and Integrative Health
-
Notice of Correction to Key Dates in RFA-CA-23-015, Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
(NOT-CA-23-072)National Cancer Institute
-
Notice of Participation of NIDDK in "RFA-NS-22-022 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)"
(NOT-DK-23-023)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Participation of NIDDK in "RFA-NS-22-025 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
(NOT-DK-23-024)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change to Eligibility Criteria in PAR-21-277 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
(NOT-GM-23-005)National Institute of General Medical Sciences
-
Notice of Change in Award Information and Related Application Instructions in PAR-21-277 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity"
(NOT-GM-23-016)National Institute of General Medical Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional)
(NOT-RM-23-018)Office of Strategic Coordination (Common Fund)
Notices of Special Interest
-
Notice of Special Interest (NOSI): Understanding Mucosal Immunity Against Enteric Eukaryotic Pathogens to Advance Discovery of New Interventions
(NOT-AI-23-045)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Promoting Research and Development of Vaccines Against Enteric Viruses
(NOT-AI-23-048)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Impacts of Psychedelic and Dissociative Drug Policy Changes on Public Health Outcomes
(NOT-DA-24-010)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Applications of Data Science in Translational Dental, Oral, and Craniofacial Research
(NOT-DE-23-002)National Institute of Dental and Craniofacial Research
-
Notice of Special Interest (NOSI): Program Priority Areas for MOSAIC UE5 - November 2023 Application Due Date
(NOT-GM-23-004)National Institute of General Medical Sciences
-
Notice of Special Interest (NOSI): Clinical Studies of CNS Complications in People with HIV
(NOT-MH-23-255)National Institute of Mental HealthNational Institute of Neurological Disorders and Stroke
-
Notice of Special Interest (NOSI): Eradication of HIV-1 from Central Nervous System Reservoirs
(NOT-MH-23-260)National Institute of Mental HealthNational Institute of Neurological Disorders and Stroke
-
Notice of Special Interest (NOSI): Neuropathogenesis of CNS Complications Associated with HIV
(NOT-MH-23-280)National Institute of Mental HealthNational Institute of Neurological Disorders and Stroke
Funding Opportunities
-
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
(PAR-23-194)National Institute on Drug AbuseApplication Receipt Date(s): January 7, 2025
-
NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
(PAR-23-197)National Eye InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
(PAR-23-207)National Institute of Mental HealthNational Institute on AgingApplication Receipt Date(s): January 6, 2025
-
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
(PAR-23-208)National Institute of Mental HealthNational Institute on AgingApplication Receipt Date(s): January 6, 2025
-
Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)
(PAR-23-213)National Institute of General Medical SciencesApplication Receipt Date(s): March 26, 2025
-
Development and Characterization of Experimental models of post-TBI ADRD (R01 - Clinical Trial Not Allowed)
(PAR-23-218)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): September 22, 2023
-
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
(RFA-AG-24-047)National Institute on AgingApplication Receipt Date(s): October 30, 2023
-
Development of Software for Data Science in Infectious and Immune-Mediated Diseases Research (U01 Clinical Trial Not Allowed)
(RFA-AI-23-038)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): October 11, 2023
-
NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
(RFA-DK-23-014)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): September 28, 2023
-
Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Acute Low Back Pain (U01) Clinical Trials Not Allowed
(RFA-FD-23-034)Food and Drug AdministrationApplication Receipt Date(s): August 15, 2023 by 11:59 PM Eastern Time Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this NOFO.
-
Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Laparoscopic Abdominal Surgeries (U01) Clinical Trials Not Allowed
(RFA-FD-23-035)Food and Drug AdministrationApplication Receipt Date(s): August 15, 2023 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
-
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
(RFA-MH-24-280)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster